التداخل بين فورموتيرول وميتوبرولول

Bronchodilators, including beta 2 -agonists, should be readily available or administered concomitantly [see Dosage and Administration (2) ].

• Beta-blockers may decrease effectiveness.

In this setting, cardioselective beta-blockers could be considered, although they should be administered with caution.

Beta-blockers Beta-adrenergic receptor antagonists (beta-blockers) and formoterol may inhibit the effect of each other when administered concurrently.

Beta-blockers not only block the therapeutic effects of beta-agonists, but may produce severe bronchospasm in COPD patients.

Therefore, patients with COPD should not normally be treated with beta-blockers.